Premium
Midazolam in conservative dentistry
Author(s) -
Dixon R. A.,
KENYON C.,
MARSH D. R. G.,
THORNTON J. A.
Publication year - 1986
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.1986.tb12788.x
Subject(s) - midazolam , medicine , sedative , anesthesia , diazepam , flumazenil , thrombophlebitis , benzodiazepine , surgery , sedation , receptor , thrombosis
Summary In a double‐blind trial, 50 patients were randomly allocated to receive up to 0.29 mg/kg diazepam (Valium 5 mg/ml) or 0.14 mg/kg of midazolam (midazolam hydrochloride 5 mg/ml) intravenously at a first session of conservative dentistry, the alternative being administered at the second session. Good operating conditions were reported under each sedative and no important physiological differences were observed. Most patients failed to return to ‘street fitness’ 30 minutes after either session of treatment. Previous reports of reduced incidence of venous thrombophlebitis with midazolam were not convincingly confirmed in this trial, but data quality was poor. For about half the patients, the amnesic effect was stronger following midazolam.